New analysis claims the FDA rushed ketamine’s approval for depression treatment

New analysis claims the FDA rushed ketamine’s approval for depression treatment
  • A new analysis in The British Journal of Psychiatry claims the FDA approval process for ketamine was rushed.
  • Only one of three clinical trials showed efficacy, while the discontinuat…
    Read More

Leave a Reply

Your email address will not be published. Required fields are marked *